Influenza in solid organ transplant recipients: epidemiology, management, and outcomes

References

• Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018 Jan;16(1):60. PubMed PMID: 29109554.
   PubMed Web of Science ®Google Scholar
• Collins JP, Campbell AP, Openo K, et al. Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015. Clin Infect Dis. 2019 Jul 11 PubMed PMID: 31298691. DOI:10.1093/cid/ciz638.
   Google Scholar
• Kumar D, Ferreira VH, Blumberg E, et al. A 5-year prospective multicenter evaluation of influenza infection in transplant recipients. Clin Infect Dis. 2018 Oct 15;67(9):1322–1329. PubMed PMID: 29635437.
   PubMed Web of Science ®Google Scholar
• Peghin M, Los-Arcos I, Hirsch HH, et al. Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction. Clin Infect Dis. 2019 Sep 13;69(7):1192–1197. PubMed PMID: 30561555.
   PubMed Web of Science ®Google Scholar
• Perez-Padilla R, de la Rosa-zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009 Aug 13;361(7):680–689. PubMed PMID: 19564631.
   PubMed Web of Science ®Google Scholar
• Lopez-Medrano F, Aguado JM, Lizasoain M, et al. Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study. Transplantation. 2007 Oct 15;84(7):851–856. 00007890-200710150-00008 [pii]. PubMed PMID: 17984837; eng.
   PubMed Web of Science ®Google Scholar
• Helantera I, Anttila VJ, Lappalainen M, et al. Outbreak of Influenza A(H1N1) in a kidney transplant unit-protective effect of vaccination. Am J Transplant. 2015 Sep;15(9):2470–2474. PubMed PMID: 25943587.
   PubMed Web of Science ®Google Scholar
• Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002 Mar;2(3):287–291. PubMed PMID: 12096793; eng.
   PubMed Web of Science ®Google Scholar
• Odongo FC, Azevedo LS, Neto ED, et al. Clinical characteristics and outcomes of influenza a infection in kidney transplant recipients: A single-center experience. Transplant Proc. 2016 Sep;48(7):2315–2318. PubMed PMID: 27742287.
   PubMed Web of Science ®Google Scholar
• Peghin M, Hirsch HH, Len O, et al. Epidemiology and immediate indirect effects of respiratory viruses in lung transplant recipients: A 5-Year prospective study. Am J Transplant. 2017 May;17(5):1304–1312. PubMed PMID: 27615811.
   PubMed Web of Science ®Google Scholar
• Bridevaux PO, Aubert JD, Soccal PM, et al. Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax. 2014 Jan;69(1):32–38. PubMed PMID: 24025442.
   PubMed Web of Science ®Google Scholar
• Ng BJ, Glanville AR, Snell G, et al. The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients. Am J Transplant. 2011 Mar;11(3):568–574. PubMed PMID: 21299829; eng.
   PubMed Web of Science ®Google Scholar
• Low CY, Kee T, Chan KP, et al. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation. 2010 Nov 15;90(9):1016–1021. PubMed PMID: 20814355; eng.
   PubMed Web of Science ®Google Scholar
• Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010 Aug;10(8):521–526. PubMed PMID: 20620116; PubMed Central PMCID: PMC3045703.
   PubMed Web of Science ®Google Scholar
• Cordero E, Perez-Romero P, Moreno A, et al. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clin Microbiol Infect. 2012 Jan;18(1):67–73. PubMed PMID: 21790857.
   PubMed Web of Science ®Google Scholar
• Mauch TJ, Bratton S, Myers T, et al. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics. 1994 Aug;94(2 Pt 1):225–229. PubMed PMID: 8036078.
   PubMed Web of Science ®Google Scholar
• Vilchez RA, Fung JJ, Kusne S. Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation. 2000 Aug 15;70(3):543–545. PubMed PMID: 10949202.
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Barba P, Arnan M, et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis. 2011 Sep;53(6):e16–9. PubMed PMID: 21865184.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Kolwijck E, Lestrade PP, et al. Influenza-associated aspergillosis in critically Ill patients. Am J Respir Crit Care Med. 2017 Aug 15;196(4):524–527. PubMed PMID: 28387526.
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe A, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018 Oct;6(10):782–792. PubMed PMID: 30076119.
   PubMed Web of Science ®Google Scholar
• Smud A, Nagel CB, Madsen E, et al. Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation. 2010 Dec 27;90(12):1458–1462. PubMed PMID: 20921933; eng.
   PubMed Web of Science ®Google Scholar
• Perez-Romero P, Aydillo TA, Perez-Ordonez A, et al. Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease. Clin Microbiol Infect. 2012 Dec;18(12):E533–E40. PubMed PMID: 23078072.
   PubMed Web of Science ®Google Scholar
• Martin-Gandul C, Mueller NJ, Pascual M, et al. The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation. Am J Transplant. 2015 Dec;15(12):3024–3040. PubMed PMID: 26474168.
   PubMed Web of Science ®Google Scholar
• Fisher CE, Preiksaitis CM, Lease ED, et al. Symptomatic respiratory virus infection and chronic lung allograft dysfunction. Clin Infect Dis. 2016 Feb 1;62(3):313–319. PubMed PMID: 26565010; PubMed Central PMCID: PMCPMC4706632.
   PubMed Web of Science ®Google Scholar
• Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019 Mar 5;68(6):e1–e47. PubMed PMID: 30566567; PubMed Central PMCID: PMCPMC6653685.
   PubMed Web of Science ®Google Scholar
• Manuel O, Estabrook M. American society of transplantation infectious diseases community of P. RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019 Sep;33(9):e13511. PubMed PMID: 30817023.
   PubMed Web of Science ®Google Scholar
• Ison MG, Sharma A, Shepard JA, et al. Outcome of influenza infection managed with oseltamivir in lung transplant recipients [Research Support, Non-U.S. Gov’t]. J Heart Lung Transplant. 2008 Mar;27(3):282–288. PubMed PMID: 18342750; eng.
   PubMed Web of Science ®Google Scholar
• Ison MG, Szakaly P, Shapira MY, et al. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients. Antivir Ther. 2012;17(6):955–964. PubMed PMID: 22728756.
   PubMed Web of Science ®Google Scholar
• Lee N, Hurt AC. Neuraminidase inhibitor resistance in influenza: a clinical perspective. Curr Opin Infect Dis. 2018 Dec;31(6):520–526. PubMed PMID: 30299356.
   PubMed Web of Science ®Google Scholar
• Gubareva LV, Besselaar TG, Daniels RS, et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. Antiviral Res. 2017 Oct;146:12–20. PubMed PMID: 28802866; PubMed Central PMCID: PMCPMC5667636.
   PubMed Web of Science ®Google Scholar
• L’Huillier AG, Abed Y, Petty TJ, et al. E119D neuraminidase mutation conferring pan-resistance to neuraminidase inhibitors in an A(H1N1)pdm09 isolate from a stem-cell transplant recipient. J Infect Dis. 2015 Dec 1;212(11):1726–1734. PubMed PMID: 25985905; PubMed Central PMCID: PMCPMC4633758.
   PubMed Web of Science ®Google Scholar
• South East Asia Infectious Disease Clinical Research N. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ. 2013 May 30;346:f3039. PubMed PMID: 23723457; PubMed Central PMCID: PMCPMC3668094.
   PubMed Web of Science ®Google Scholar
• Lee N, Hui DS, Zuo Z, et al. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. Clin Infect Dis. 2013 Dec;57(11):1511–1519. PubMed PMID: 24046309.
   PubMed Web of Science ®Google Scholar
• Marty FM, Vidal-Puigserver J, Clark C, et al. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med. 2017 Feb;5(2):135–146. PubMed PMID: 28094141.
   PubMed Web of Science ®Google Scholar
• Ison MG, Hui DS, Clezy K, et al. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults. Antivir Ther. 2013;18(5):651–661. PubMed PMID: 23111657.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Bao Y, Beeler J, et al. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis. 2017 Dec;17(12):1255–1265. PubMed PMID: 28958678; PubMed Central PMCID: PMCPMC5777222.
   PubMed Web of Science ®Google Scholar
• Duval X, van der Werf S, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010 Nov 2;7(11):e1000362. PubMed PMID: 21072246; PubMed Central PMCID: PMCPMC2970549.
   PubMed Web of Science ®Google Scholar
• de Jong MD, Ison MG, Monto AS, et al. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients. Clin Infect Dis. 2014 Dec 15;59(12):e172–e85. PubMed PMID: 25115871.
   PubMed Web of Science ®Google Scholar
• Watcharananan SP, Suwatanapongched T, Wacharawanichkul P, et al. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure. Transpl Infect Dis. 2010 Apr;12(2):127–131. TID493 [pii]. PubMed PMID: 20102550; eng.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Adams O, Schuster FR, et al. Efficient control of pandemic 2009 H1N1 virus infection with intravenous zanamivir despite the lack of immune function. Transpl Infect Dis. 2012 Dec;14(6):657–659. PubMed PMID: 23013415.
   PubMed Web of Science ®Google Scholar
• Dohna-Schwake C, Schweiger B, Felderhoff-Muser U, et al. Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications. Transplantation. 2010 Jul 27;90(2):223–224. PubMed PMID: 20644456.
   PubMed Web of Science ®Google Scholar
• Anraku M, Husain S, Mazulli T, et al. Peri-operative novel 2009 H1N1 influenza virus infection successfully treated with oseltamivir and zanamivir in a lung transplant recipient. J Heart Lung Transplant. 2011 Mar;30(3):354. PubMed PMID: 21094056.
   PubMed Web of Science ®Google Scholar
• Shetty AK, Ross GA, Pranikoff T, et al. Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient. Pediatr Transplant. 2012 Aug;16(5):E153–E7. PubMed PMID: 22764830.
   PubMed Web of Science ®Google Scholar
• Campbell AP, Jacob ST, Kuypers J, et al. Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: detection of extrapulmonary H1N1 RNA and use of intravenous peramivir. Ann Intern Med. 2010 May 4;152(9):619–620. PubMed PMID: 20439588; PubMed Central PMCID: PMCPMC2976592.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Chang SC, Kim MJ, et al. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial. Clin Infect Dis. 2010 Nov 15;51(10):1167–1175. PubMed PMID: 20936975.
   PubMed Web of Science ®Google Scholar
• Kashiwagi S, Watanabe A, Ikematsu H, et al. Long-acting neuraminidase inhibitor laninamivir octanoate as post-exposure prophylaxis for influenza. Clin Infect Dis. 2016 Aug 1;63(3):330–337. PubMed PMID: 27118785; PubMed Central PMCID: PMCPMC4946013.
   PubMed Web of Science ®Google Scholar
• Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018 Sep 6;379(10):913–923. PubMed PMID: 30184455.
   PubMed Web of Science ®Google Scholar
• Uehara T, Hayden FG, Kawaguchi K, et al. Treatment-emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza. J Infect Dis. 2019 Jul 16 PubMed PMID: 31309975. DOI:10.1093/infdis/jiz244.
   Google Scholar
• Takashita E, Ichikawa M, Morita H, et al. Human-to-Human Transmission of Influenza A(H3N2) virus with reduced susceptibility to Baloxavir, Japan, February 2019. Emerg Infect Dis. 2019 Nov;25(11):2108–2111. PubMed PMID: 31436527.
   PubMed Web of Science ®Google Scholar
• Schuurmans MM, Tini GM, Dalar L, et al. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant. 2011 Jun;30(6):685–690. doi: S1053-2498(11)00738-8 [pii]. PubMed PMID: 21444211; eng.
   PubMed Web of Science ®Google Scholar
• Hurst FP, Lee JJ, Jindal RM, et al. Outcomes associated with influenza vaccination in the first year after kidney transplantation. Clin J Am Soc Nephrol. 2011 May;6(5):1192–1197. doi: CJN.05430610 [pii]. PubMed PMID: 21511837; PubMed Central PMCID: PMC3087788. eng.
   PubMed Web of Science ®Google Scholar
• Chong PP, Handler L, Weber DJ. A systematic review of safety and immunogenicity of influenza vaccination strategies in solid organ transplant recipients. Clin Infect Dis. 2018 May 17;66(11):1802–1811. PubMed PMID: 29253095.
   PubMed Web of Science ®Google Scholar
• Schaffer SA, Husain S, Delgado DH, et al. Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transplant. 2011 Dec;11(12):2751–2754. PubMed PMID: 21906258.
   PubMed Web of Science ®Google Scholar
• Katerinis I, Hadaya K, Duquesnoy R, et al. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant. 2011 Aug;11(8):1727–1733. PubMed PMID: 21672157; eng.
   PubMed Web of Science ®Google Scholar
• Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant. 2008 Feb;8(2):332–337. PubMed PMID: 18162092. .
   PubMed Web of Science ®Google Scholar
• Dos Santos G, Haguinet F, Cohet C, et al. Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series. Vaccine. 2016 Jun 30;34(31):3598–3606. PubMed PMID: 27216760.
   PubMed Web of Science ®Google Scholar
• Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant. 2009 Oct;9(10):2346–2354. PubMed PMID: 19656126.
   PubMed Web of Science ®Google Scholar
• Burbach G, Bienzle U, Stark K, et al. Influenza vaccination in liver transplant recipients. Transplantation. 1999 Mar 15;67(5):753–755. PubMed PMID: 10096534.
   PubMed Web of Science ®Google Scholar
• Vermeiren P, Aubert V, Sugamele R, et al. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transpl Int. 2014 Sep;27(9):903–908. PubMed PMID: 24797932.
   PubMed Web of Science ®Google Scholar
• Manuel O, Pascual M, Hoschler K, et al. Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis. 2011 Jan 15;52(2):248–256. doi: ciq104 [pii]. PubMed PMID: 21288852; eng.
   PubMed Web of Science ®Google Scholar
• Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis. 1996 Feb;22(2):295–302. PubMed PMID: 8838186.
   PubMed Web of Science ®Google Scholar
• Birdwell KA, Ikizler MR, Sannella EC, et al. Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis. 2009 Jul;54(1):112–121. PubMed PMID: 19185404; PubMed Central PMCID: PMC3772511.
   PubMed Web of Science ®Google Scholar
• Mulley WR, Visvanathan K, Hurt AC, et al. Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination. Kidney Int. 2012 Jul;82(2):212–219. PubMed PMID: 22495292.
   PubMed Web of Science ®Google Scholar
• Cordero E, Perez-Ordonez A, Aydillo TA, et al. Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients. Am J Transplant. 2011 Oct;11(10):2205–2213. PubMed PMID: 21831151.
   PubMed Web of Science ®Google Scholar
• Orcurto A, Pascual M, Hoschler K, et al. Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients. Transplantation. 2012 Sep 27;94(6):630–636. PubMed PMID: 22895612.
   PubMed Web of Science ®Google Scholar
• Fernandez-Ruiz M, Humar A, Baluch A, et al. Baseline serum interleukin-6 to interleukin-2 ratio is associated with the response to seasonal trivalent influenza vaccine in solid organ transplant recipients. Vaccine. 2015 Dec 16;33(51):7176–7182. PubMed PMID: 26555352.
   PubMed Web of Science ®Google Scholar
• Egli A, Santer DM, O’Shea D, et al. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog. 2014 Dec;10(12):e1004556. PubMed PMID: 25503988; PubMed Central PMCID: PMCPMC4263767.
   PubMed Web of Science ®Google Scholar
• Natori Y, Shiotsuka M, Slomovic J, et al. A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients. Clin Infect Dis. 2018 May 17;66(11):1698–1704. PubMed PMID: 29253089.
   PubMed Web of Science ®Google Scholar
• Mombelli M, Rettby N, Perreau M, et al. Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial. Vaccine. 2018 Oct 1;36(41):6163–6169. PubMed PMID: 30181045.
   PubMed Web of Science ®Google Scholar
• GiaQuinta S, Michaels MG, McCullers JA, et al. Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients. Pediatr Transplant. 2015 Mar;19(2):219–228. PubMed PMID: 25523718.
   PubMed Web of Science ®Google Scholar
• Cordero E, Roca-Oporto C, Bulnes-Ramos A, et al. Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial. Clin Infect Dis. 2017 Apr 1;64(7):829–838. PubMed PMID: 28362949.
   PubMed Web of Science ®Google Scholar
• Kumar D, Campbell P, Hoschler K, et al. Randomized controlled trial of adjuvanted versus nonadjuvanted influenza vaccine in kidney transplant recipients. Transplantation. 2016 Mar;100(3):662–669. PubMed PMID: 26335915.
   PubMed Web of Science ®Google Scholar
• Morelon E, Pouteil Noble C, Daoud S, et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine. 2010 Oct 4;28(42):6885–6890. PubMed PMID: 20709000.
   PubMed Web of Science ®Google Scholar
• Manuel O, Humar A, Berutto C, et al. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant. 2011 Jun;30(6):679–684. PubMed PMID: 21377898.
   PubMed Web of Science ®Google Scholar
• Baluch A, Humar A, Eurich D, et al. Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. Am J Transplant. 2013 Apr;13(4):1026–1033. PubMed PMID: 23406320.
   PubMed Web of Science ®Google Scholar
• Beyer WE, Palache AM, Luchters G, et al. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res. 2004 Jul;103(1–2):125–132. PubMed PMID: 15163500.
   PubMed Web of Science ®Google Scholar
• Cox RJ. Correlates of protection to influenza virus, where do we go from here? Hum Vaccin Immunother. 2013 Feb;9(2):405–408. PubMed PMID: 23291930; PubMed Central PMCID: PMCPMC3859764.
   PubMed Web of Science ®Google Scholar
• Hobson D, Curry RL, Beare AS, et al. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972 Dec;70(4):767–777. PubMed PMID: 4509641; PubMed Central PMCID: PMCPMC2130285.
   PubMedGoogle Scholar
• Hirzel C, Ferreira VH, L’Huillier AG, et al. Humoral response to natural influenza infection in solid organ transplant recipients. Am J Transplant. 2019 Aug;19(8):2318–2328. PubMed PMID: 30748090.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Iimmunol. 2006 May 15;176(10):6333–6339. PubMed PMID: 16670345.
   PubMed Web of Science ®Google Scholar
• Sridhar S, Begom S, Bermingham A, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013 Oct;19(10):1305–1312. PubMed PMID: 24056771.
   PubMed Web of Science ®Google Scholar
• Hequet D, Pascual M, Lartey S, et al. Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies. Vaccine. 2016 Jun 30;34(31):3576–3583. PubMed PMID: 27219339.
   PubMed Web of Science ®Google Scholar
• L’Huillier AG, Ferreira VH, Hirzel C, et al. Cell-mediated immune responses after influenza vaccination of solid organ transplant recipients: a secondary outcomes analysis of a randomized controlled trial. J Infect Dis. 2019 Sep 24 PubMed PMID: 31550354. DOI:10.1093/infdis/jiz471.
   PubMedGoogle Scholar
• Feldman AG, Atkinson K, Wilson K, et al. Underimmunization of the solid organ transplant population: an urgent problem with potential digital health solutions. Am J Transplant. 2019 Sep 25 PubMed PMID: 31553135. DOI:10.1111/ajt.15605.
   PubMed Web of Science ®Google Scholar
• Harris K, Baggs J, Davis RL, et al. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005. Vaccine. 2009 Apr 14;27(17):2335–2341. PubMed PMID: 19428848. .
   PubMed Web of Science ®Google Scholar
• Restivo V, Vizzini G, Mularoni A, et al. Determinants of influenza vaccination among solid organ transplant recipients attending Sicilian reference center. Hum Vaccin Immunother. 2017 Feb;13(2):346–350. PubMed PMID: 27929758; PubMed Central PMCID: PMCPMC5328212.
   PubMed Web of Science ®Google Scholar
• Lee DH, Boyle SM, Malat G, et al. Low rates of vaccination in listed kidney transplant candidates. Transpl Infect Dis. 2016 Feb;18(1):155–159. PubMed PMID: 26461052.
   PubMed Web of Science ®Google Scholar
• Chon WJ, Kadambi PV, Harland RC, et al. Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol. 2010 Sep;5(9):1637–1641. PubMed PMID: 20595695; PubMed Central PMCID: PMCPMC2974405.
   PubMed Web of Science ®Google Scholar
• Kasper AK, Pallotta AM, Kovacs CS, et al. Infectious diseases consult improves vaccination adherence in kidney transplant candidates. Vaccine. 2018 Aug 16;36(34):5112–5115. PubMed PMID: 30049629.
   PubMed Web of Science ®Google Scholar
• Nachbagauer R, Palese P. Is a universal influenza virus vaccine possible? Annu Rev Med. 2019 Oct 10. PubMed PMID: 31600454. DOI:10.1146/annurev-med-120617-041310.
   PubMedGoogle Scholar
• Nakaya HI, Clutterbuck E, Kazmin D, et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1853–1858. PubMed PMID: 26755593; PubMed Central PMCID: PMCPMC4763735.
   PubMed Web of Science ®Google Scholar